SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-028509
Filing Date
2019-08-05
Accepted
2019-08-05 07:01:57
Documents
57
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nerv-10q_20190630.htm 10-Q 1169646
2 EX-31.1 nerv-ex311_7.htm EX-31.1 17189
3 EX-31.2 nerv-ex312_9.htm EX-31.2 16746
4 EX-32.1 nerv-ex321_6.htm EX-32.1 9529
  Complete submission text file 0001564590-19-028509.txt   5558448

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nerv-20190630.xml EX-101.INS 1269768
6 XBRL TAXONOMY EXTENSION SCHEMA nerv-20190630.xsd EX-101.SCH 43110
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nerv-20190630_cal.xml EX-101.CAL 38462
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nerv-20190630_def.xml EX-101.DEF 174533
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nerv-20190630_lab.xml EX-101.LAB 375961
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nerv-20190630_pre.xml EX-101.PRE 293434
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36517 | Film No.: 19997525
SIC: 2834 Pharmaceutical Preparations